| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director | Common Stock | 47K | $164K | $3.49 | Aug 12, 2024 | Direct |
| BioXcel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 17K | Jun 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Aug 12, 2024 | 1 | -$81.5K | 4 | Aug 13, 2024 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 18, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Nov 7, 2023 | 1 | -$70.8K | 4 | Nov 9, 2023 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jun 26, 2023 | 1 | $0 | 4 | Jun 28, 2023 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 13, 2023 | 2 | -$46.6K | 4 | Jun 15, 2023 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Aug 9, 2022 | 1 | -$88.8K | 4 | Aug 10, 2022 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 5, 2022 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jul 1, 2022 | 0 | $0 | 3 | Jul 5, 2022 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Mar 16, 2022 | 1 | -$71.8K | 4 | Mar 17, 2022 | Director |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |